文献速递前列腺癌

68Ga-PSMA PET/CT预测中高危前列腺癌根治术后生化持续

Gallium-68-prostate-specific membrane antigen (68 Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer.
PubMed 文献 · BJU Int · 2019-04-07

该研究纳入140例中高危前列腺癌患者,术前均行68Ga-PSMA-11 PET/CT和mpMRI,根治性前列腺切除及扩大盆腔淋巴结清扫后中位110天检测PSA。PSMA PET/CT盆腔淋巴结阳性者生化持续率为50%,阴性者为16.7%(P<0.05),且PSMA阳性淋巴结对生化持续的预测价值优于cT分期、PSA和Gleason评分。

要点

  • PSMA PET/CT盆腔淋巴结阳性者术后生化持续率50%,阴性者16.7%。
  • PSMA PET/CT检测淋巴结转移灵敏度53%、特异度88%。
  • PSMA阳性淋巴结对生化持续的预测优于cT分期、PSA和Gleason评分。

核心结论

  • 68Ga-PSMA-11 PET/CT对中高危前列腺癌根治术后生化持续具有高度预测价值,应重视其信息告知作用。

研究设计与样本

  • 回顾性分析140例中高危前列腺癌患者,术前均行68Ga-PSMA-11 PET/CT和mpMRI,随后行根治性前列腺切除及扩大盆腔淋巴结清扫。

主要发现

  • 27.1%的患者PSMA PET/CT显示盆腔淋巴结阳性。
  • PSMA PET/CT检测淋巴结转移的灵敏度和特异度分别为53%和88%,mpMRI分别为14%和99%。
  • 总体生化持续率为25.7%,PSMA PET/CT淋巴结阴性者生化持续率16.7%,阳性者50%(P<0.05)。
  • 校正手术切缘状态后,PSMA阳性盆腔淋巴结对术后生化持续的预测价值优于cT分期、PSA水平和Gleason评分。

关键数值与推荐

  • 生化持续定义为根治术后PSA≥0.03 ng/mL。
  • 术后PSA检测中位时间为110天(四分位距49-132天)。

临床怎么用

  • 对中高危前列腺癌患者,术前68Ga-PSMA-11 PET/CT可帮助识别盆腔淋巴结阳性者,后者术后生化持续风险显著升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the value of gallium-68-prostate-specific membrane antigen (68 Ga-PSMA)-11 positron emission tomography (PET) /computed tomography (CT) in men with newly diagnosed prostate cancer. PATIENTS AND METHODS: We analysed results of 140 men with intermediate- and high-risk prostate cancer. All men underwent 68 Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging (mpMRI) before radical prostatectomy (RP) with extended pelvic lymph node (LN) dissection. For each patient, the clinical and pathological features were recorded. Prostate-specific antigen (PSA) was documented at staging scan, and after RP, at a median (interquartile range) of 110 (49-132) days. A PSA level of ≥0.03 ng/mL was classified as biochemical persistence (BCP). Logistic regression was performed for association of clinical variables and BCP. RESULTS: In these 140 patients with intermediate- and high-risk prostate cancer, 27.1% had PSMA PET/CT-positive findings in the pelvic LNs. Sensitivity and specificity for detection of LN metastases were 53% and 88% (PSMA PET/CT) and 14% and 99% (mpMRI), respectively. The overall BCP rate was 25.7%. The BCP rate was 16.7% in men who were PSMA PET/CT LN-negative compared to 50% in men who were PSMA PET/CT LN-positive (P < 0.05). The presence of PSMA-positive pelvic LNs was more predictive of BCP after RP than cT-stage, PSA level, and the Gleason score, adjusted for surgical margins status. CONCLUSIONS: 68 Ga-PSMA-11 PET/CT is highly predictive of BCP after RP, and should play an important role informing men with intermediate- or high-risk prostate cancer.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. van Leeuwen PJ, Donswijk M, Nandurkar R, et al. Gallium-68-prostate-specific membrane antigen (68 Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer. BJU Int. 2019. PMID: 30074667. doi:10.1111/bju.14506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。